Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AEHR NASDAQ:CTKB NASDAQ:LAB NASDAQ:SEER On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAEHRAehr Test Systems$16.84-0.4%$13.80$6.27▼$23.00$505.57M2.352.10 million shs1.16 million shsCTKBCytek Biosciences$3.64+1.1%$3.29$2.37▼$7.63$455.97M1.34933,205 shs1.54 million shsLABStandard BioTools$1.30-2.3%$1.21$0.92▼$2.32$505.16M1.321.54 million shs1.51 million shsSEERSeer$2.13+0.5%$2.12$1.59▼$2.63$124.80M1.5787,860 shs107,673 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAEHRAehr Test Systems-0.36%-22.54%+11.30%+93.34%-10.76%CTKBCytek Biosciences+1.11%-1.36%+0.83%-5.70%-45.75%LABStandard BioTools-2.26%-7.14%-5.11%+8.33%-41.96%SEERSeer+0.47%-3.18%-3.62%+3.90%+7.58%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAEHRAehr Test Systems1.3478 of 5 stars0.01.00.00.02.62.51.9CTKBCytek Biosciences2.4837 of 5 stars3.12.00.00.02.74.20.0LABStandard BioTools3.4899 of 5 stars3.53.00.00.04.13.30.6SEERSeer1.9866 of 5 stars3.01.00.00.01.93.30.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAEHRAehr Test Systems 0.00N/AN/AN/ACTKBCytek Biosciences 2.20Hold$5.6053.85% UpsideLABStandard BioTools 3.00Buy$2.5092.31% UpsideSEERSeer 2.00Hold$3.0040.85% UpsideCurrent Analyst Ratings BreakdownLatest SEER, LAB, AEHR, and CTKB Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/17/2025LABStandard BioToolsTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy5/28/2025CTKBCytek BiosciencesMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$9.00 ➝ $7.005/12/2025CTKBCytek BiosciencesThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSell ➝ Sell$3.50 ➝ $3.005/9/2025CTKBCytek BiosciencesTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold$4.00(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAEHRAehr Test Systems$58.97M8.54$0.11 per share157.18$4.11 per share4.10CTKBCytek Biosciences$200.45M2.30$0.04 per share103.74$3.07 per share1.19LABStandard BioTools$174.43M2.83N/AN/A$1.27 per share1.02SEERSeer$14.17M8.85N/AN/A$5.54 per share0.38Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAEHRAehr Test Systems-$3.91M-$0.13N/A76.55N/A-6.63%-0.15%-0.13%10/9/2025 (Estimated)CTKBCytek Biosciences-$6.02M-$0.09N/A∞N/A-5.71%-2.90%-2.30%8/6/2025 (Estimated)LABStandard BioTools-$138.88M-$0.35N/AN/AN/A-78.24%-22.44%-16.74%8/11/2025 (Estimated)SEERSeer-$86.60M-$1.41N/AN/AN/A-560.90%-24.69%-22.13%8/6/2025 (Estimated)Latest SEER, LAB, AEHR, and CTKB EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/11/2025Q2 2025LABStandard BioTools-$0.04N/AN/AN/A$39.83 millionN/A8/6/2025Q2 2025CTKBCytek Biosciences-$0.02N/AN/AN/A$46.03 millionN/A8/6/2025Q2 2025SEERSeer-$0.39N/AN/AN/A$3.75 millionN/A7/8/2025Q4 2025AEHRAehr Test Systems-$0.02-$0.01+$0.01-$0.10$14.83 million$14,100.00 billion5/13/2025Q1 2025SEERSeer-$0.37-$0.34+$0.03-$0.34$3.25 million$4.21 million5/8/2025Q1 2025CTKBCytek Biosciences-$0.04-$0.09-$0.05-$0.09$43.18 million$41.46 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAEHRAehr Test SystemsN/AN/AN/AN/AN/ACTKBCytek BiosciencesN/AN/AN/AN/AN/ALABStandard BioToolsN/AN/AN/AN/AN/ASEERSeerN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAEHRAehr Test SystemsN/A5.683.07CTKBCytek BiosciencesN/A5.624.95LABStandard BioToolsN/A6.125.37SEERSeerN/A19.3418.81Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAEHRAehr Test Systems69.69%CTKBCytek Biosciences69.46%LABStandard BioTools53.74%SEERSeer75.20%Insider OwnershipCompanyInsider OwnershipAEHRAehr Test Systems6.20%CTKBCytek Biosciences10.33%LABStandard BioTools23.16%SEERSeer11.28%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAEHRAehr Test Systems9029.92 million28.06 millionOptionableCTKBCytek Biosciences500126.66 million113.58 millionOptionableLABStandard BioTools620379.82 million291.86 millionOptionableSEERSeer16058.87 million52.23 millionOptionableSEER, LAB, AEHR, and CTKB HeadlinesRecent News About These CompaniesUAE: Al Seer Marine’s fleet expansion drives 20% higher revenues in H1-25August 1 at 2:16 AM | zawya.comZProphet One God shares doom prophecy about Lil Win, video stirs controversyJuly 31 at 4:14 PM | msn.comSeer to Participate in the Canaccord Genuity 45th Annual Growth ConferenceJuly 31 at 4:05 PM | globenewswire.comSeer (SEER) Expected to Announce Quarterly Earnings on WednesdayJuly 31 at 10:49 AM | marketbeat.comSeer Faces Nasdaq Compliance Challenge After Annual MeetingJuly 31 at 2:36 AM | theglobeandmail.comLufthansa, Fraport, and zeroG drive innovation at Frankfurt AirportJuly 30 at 10:55 AM | breakingtravelnews.comBAl Seer Marine reports AED698 million in revenue for H1 2025July 30 at 10:55 AM | msn.comSeer (NASDAQ:SEER) Stock Price Down 0.9% - Should You Sell?July 30 at 2:59 AM | americanbankingnews.comSeer (NASDAQ:SEER) Trading Down 0.9% - Time to Sell?July 30 at 2:57 AM | marketbeat.comSeer Green man says having Birmingham NHS surgery saved jobJuly 29, 2025 | msn.comAl Seer Marine reports increase in operating profit to AED 156mlnJuly 29, 2025 | zawya.comZWhen all are treated equally, conflicts end, peace prevails, says Dingaleshwar SwamiJuly 28, 2025 | thehindu.com2023 election seer returns with 2027 forecast, predicts outcome of electionJuly 26, 2025 | msn.comLufthansa, Fraport partner on AI tech for aircraft handling at Frankfurt AirportJuly 25, 2025 | airport-technology.comALufthansa, Fraport, Zerog Drive Innovation At FRAJuly 25, 2025 | airwaysmag.comALufthansa, Fraport, and zeroG Introduce AI-Based Camera 'Seer' at Frankfurt AirportJuly 25, 2025 | aviationpros.comASeer to Report Second Quarter 2025 Financial Results on August 6, 2025July 22, 2025 | globenewswire.comSadhguru visits Suttur Mutt to thank seerJuly 21, 2025 | timesofindia.indiatimes.comPanchamasali seer hospitalised after food poisoningJuly 19, 2025 | timesofindia.indiatimes.comPanchamasali Trust mulls alternative to seer in KudalasangamaJuly 19, 2025 | timesofindia.indiatimes.comPanchamasali rift: Trust decides to choose a new seerJuly 19, 2025 | thehindu.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesRocket Lab: A Parabolic Run Meets a Healthy PullbackBy Ryan Hasson | July 23, 2025View Rocket Lab: A Parabolic Run Meets a Healthy PullbackThe Meteoric Rise of Rocket Lab: A Space Stock to WatchBy Ryan Hasson | July 11, 2025View The Meteoric Rise of Rocket Lab: A Space Stock to WatchRocket Lab: Latest Catalysts Bolster the Bull CaseBy Ryan Hasson | July 3, 2025View Rocket Lab: Latest Catalysts Bolster the Bull CaseRocket Lab Gets New Street-High Price Target from Citi By Ryan Hasson | July 16, 2025View Rocket Lab Gets New Street-High Price Target from Citi D-Wave, SuperQ, and Verge: A New Path Forward for Quantum?By Nathan Reiff | July 28, 2025View D-Wave, SuperQ, and Verge: A New Path Forward for Quantum?SEER, LAB, AEHR, and CTKB Company DescriptionsAehr Test Systems NASDAQ:AEHR$16.84 -0.06 (-0.36%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$16.88 +0.04 (+0.24%) As of 08/1/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices. The company also offers FOX-CP system, a low-cost single-wafer compact test solution for logic, memory, and photonic devices; FOX WaferPak Contactor, a full wafer contactor capable of testing wafers up to 300mm that enables integrated circuit manufacturers to perform test, burn-in, and stabilization of full wafers on the FOX-P systems. In addition, it provides FOX DiePak Carrier, a reusable temporary package that enables IC manufacturers to perform final test and burn-in of bare die and modules; and FOX DiePak Loader. The company was incorporated in 1977 and is headquartered in Fremont, California.Cytek Biosciences NASDAQ:CTKB$3.64 +0.04 (+1.11%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$3.64 -0.01 (-0.14%) As of 08/1/2025 06:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.Standard BioTools NASDAQ:LAB$1.30 -0.03 (-2.26%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$1.30 -0.01 (-0.38%) As of 08/1/2025 04:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument. It also provides genomics, such as X9 Real-Time PCR System, a real-time PCR analytical instrument including pre-processing steps for microfluidics-based workflows using (integrated fluidic circuit) IFCs; and IFC Controllers, a controller which is designed to work with IFC formats. In addition, the company offers analytical instruments comprising Biomark HD system, a real-time PCR analytical instrument for microfluidics-based workflows using prepared IFCs. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.Seer NASDAQ:SEER$2.13 +0.01 (+0.47%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$2.13 0.00 (0.00%) As of 08/1/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale AbbVie Stock Eyes Breakout as Pipeline and Profits Grow Why Bloom Energy Stock Could Break to New Highs Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
